Literature DB >> 23145794

How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.

Breno Fiúza Cruz1, Camilo Brandão de Resende, Mery Natali Abreu, Fábio Lopes Rocha, Antonio Lúcio Teixeira, Richard S E Keefe, João Vinícius Salgado.   

Abstract

INTRODUCTION: Interview-based scales can be used as coprimary measures to complement the assessment of cognitive impairment in schizophrenia. One major question that arises from the use of such tools is how specific they are in relation to other psychopathological domains. We analyse the specificity of the Positive and Negative Syndrome Scale (PANSS) negative subscale and the Schizophrenia Cognition Rating Scale (SCoRS).
METHODS: We performed a principal component analysis (PCA) of PANSS negative subscale, rated by the interviewer, and SCoRS ratings from three different sources (patient, informant, and interviewer) in 101 patients with schizophrenia. Additionally, we correlated mean SCoRS ratings to PANSS negative subscale items to determine whether any PANSS item is particularly related to cognition.
RESULTS: The PCA showed that the two first components, which explained approximately 40% of the total variance of the scales, represent the SCoRS ratings and the PANSS negative subscale ratings, respectively. The mean interviewer SCoRS was significantly correlated with the PANSS negative Item 5 (difficulty in abstract thinking) and with the mean PANSS negative subscale. The latter correlation was no longer significant when "difficulty in abstract thinking" was eliminated from PANSS negative subscale.
CONCLUSIONS: In general, SCoRS and PANSS negative subscale scores address different constructs; however, the PANSS negative item "difficulty in abstract thinking" seems to address a cognitive dimension.

Entities:  

Mesh:

Year:  2012        PMID: 23145794     DOI: 10.1080/13546805.2012.730995

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  4 in total

1.  Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.

Authors:  Breno F Cruz; Camilo B de Resende; Carolina F Carvalhaes; Clareci S Cardoso; Antonio L Teixeira; Richard S Keefe; Fábio L Rocha; João V Salgado
Journal:  Braz J Psychiatry       Date:  2016-06-14       Impact factor: 2.697

2.  Cognitive Implications of Correlated Structural Network Changes in Schizophrenia.

Authors:  Dawn M Jensen; Elaheh Zendrehrouh; Vince Calhoun; Jessica A Turner
Journal:  Front Integr Neurosci       Date:  2022-01-20

3.  Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale.

Authors:  Kuan-Wei Huang; Pao-Yen Lin; Yu Lee; Yu-Chi Huang; Chi-Fa Hung; Sheng-Yu Lee; Chih-Ken Chen; Liang-Jen Wang
Journal:  Psychiatry Investig       Date:  2022-07-21       Impact factor: 3.202

4.  Are negative symptoms in schizophrenia a distinct therapeutic target?

Authors:  Octavia Oana Capatina; Ioana Valentina Miclutia
Journal:  Clujul Med       Date:  2018-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.